NIH Director Francis S. Collins, M.D., Ph.D., keeps the public posted on fascinating NIH-supported research in biweekly posts on the NIH Director's Blog. The blog features the work of scientists from many of NIH's institutes and centers, as well as NIH grantees and collaborators, and NIAID is no exception. Check out these three recent posts highlighting NIAID advances:
At the height of "tick check" season, Dr. Collins clued us into an experimental technology that may help diagnose tickborne diseases. The Tick-Borne Disease (TBD) Serochip, developed by NIAID grantees at Columbia University’s Mailman School of Public Health, uses a single sample of blood to simultaneously detect and distinguish among antibodies associated with exposure to eight common tickborne pathogens. Read more.
By overlaying structural protein data with an image from a powerful microscope, NIAID grantees at The Catholic University of America created these award-winning images of bacteriophage T4, a virus that infects the bacteria Escherichia coli. Read more.
When a 34-year-old American health-care worker came to the NIH Clinical Center to receive critical care for his Ebola infection, NIAID clinician-scientists were an integral part of the team that helped him survive. This team also gathered vital information to monitor how his immune system reacted over the course of his Ebola infection—providing important insights for the prevention and treatment of the disease. Read more.